SHR-A2102 targets Nectin-4 on the cell surface, is internalized, and releases a topoisomerase I inhibitor that blocks DNA replication and induces apoptosis. DNA topoisomerase I is the intracellular enzyme inhibited by the payload, not the antigen that directs cell killing.